论文部分内容阅读
近年来,甲状腺乳头状癌(PTC)发病率呈全球化升高趋势,成为发病率增长最快的实体肿瘤之一,且有继续升高的趋势。2014年世界卫生组织(WHO)公布的全球癌症报告指出甲状腺癌新发病例中>50%为甲状腺微小乳头状癌(PTMC)。目前,PTMC在国内许多临床中心诊疗的甲状腺癌中占重要权重,这与近年来检验诊断技术水平的提高和仪器分辨率的提升密不可分。PTMC的临床问题也就自然成为专业学者必须面对和解
In recent years, the incidence of papillary thyroid carcinoma (PTC) showed a global trend of increasing and becoming one of the most rapidly growing solid tumors, with a tendency to continue to increase. The 2014 World Health Organization (WHO) Global Cancer Report states that> 50% of new cases of thyroid cancer are papillary thyroid carcinoma (PTMC). At present, PTMC plays an important role in the diagnosis and treatment of thyroid cancer in many clinical centers in China. This is closely related to the improvement of diagnostic techniques and the resolution of instruments in recent years. The clinical problems of PTMC naturally become professional scholars must face reconciliation